I was worried I wouldn’t appear too excited about the Christmas present. Because I wasn’t really.
Profile: Doug Burr
By
James M. Berklan
Oct 01, 2016
One thing is sure: Doug Burr has few peers, if any, in how he studies and calculates ways to better care for people, and get policy right.
LTC Pharmacy: Medi-chaos?
By
James M. Berklan
Feb 09, 2005
Nursing home operators and pharmacies worry about how they
are going to implement the new Medicare drug benefit in time
Job well done, Grosso has eye out for next adventure
By
James M. Berklan
Apr 12, 2018
Frank Grosso has done a lot in his 67 years. But he’s not done. That much he wants to make abundantly clear.
Information Technology: Wireless? Why not
By
James M. Berklan
Jun 13, 2005
Wireless nurse-call systems are creeping into nursing homes more often — regardless of what regulations say or imply.
Nobody’s ready to call it a tidal wave yet. But there are signs of an undercurrent...
Take-out or the ‘in’ thing?
By
James M. Berklan
Mar 22, 2004
There are signs that a tight labor market may be leading more providers back to contract therapy services
Going viral: A day without complaints brings personal discoveries
By
James M. Berklan
Aug 13, 2014
Writers are expected to promote their work, especially blog posts like this, virtually any way they can. But I’ll admit maybe this one isn’t for you. After all, you’re likely working...
$15 per hour is way too low for this nursing home operator
By
James M. Berklan
Jul 31, 2019
Midnight parties, $17 per hour aide wages and an aggressive acquisition strategy? They’re at it again.
The best columns of 2021 on mcknights.com
By
James M. Berklan
Dec 21, 2021
With December nearing its end, we took the opportunity to see which blog postings at mcknights.com were the most popular with McKnight’s Long-Term Care News readers in 2020. This list details some of...
As nursing homes fret COVID-19 vaccine distribution, only 14% say they’ll mandate it for staff
By
James M. Berklan
Dec 18, 2020
Nursing home operators continue to worry about the timing and quantities of newly approved COVID-19 vaccines reaching them this week and next, but some of the fretting could be for nought. Less than 15%...